This inventor holds 1 USPTO granted patent. Top assignees: Brandeis University, The Brigham and Women's Hospital, Inc., University of Georgia Research Foundation Inc. Active years: 2018.
Company Filing History:


Years Active: 2018
Title: Sushil K Maurya: Innovator in Gastrointestinal Treatments
Introduction
Sushil K Maurya is a notable inventor based in Leeds, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of gastrointestinal microbial infections. His innovative work has led to the development of compounds that target specific parasitic infections in mammals.
Latest Patents
Sushil K Maurya holds a patent for "Compounds and methods for treating mammalian gastrointestinal microbial infections." This patent describes compounds and their pharmaceutically acceptable salts and prodrugs, which serve as inhibitors of IMPDH. The invention emphasizes the selective inhibition of parasitic IMPDH compared to host IMPDH. Additionally, it provides pharmaceutical compositions that include these compounds, along with methods for treating various parasitic and bacterial infections in mammals. The compounds can be utilized alone or in combination with other therapeutic agents, such as anti-virals, anti-inflammatory agents, antimicrobials, and immunosuppressants.
Career Highlights
Throughout his career, Sushil K Maurya has worked with esteemed institutions, including Brandeis University and the University of Georgia Research Foundation, Inc. His research has focused on developing innovative solutions to combat gastrointestinal infections, showcasing his dedication to improving health outcomes.
Collaborations
Sushil has collaborated with notable colleagues, including Lizbeth K Hedstrom and Gregory D Cuny. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Sushil K Maurya's work in the field of gastrointestinal treatments exemplifies the impact of innovative research on healthcare. His patented compounds offer promising solutions for treating infections, highlighting the importance of continued innovation in medicine.